AIML Subsidiary NeuralCloud Solutions and Heartdent Center Ltd. Launch Pilot Project to Advance Cardiac Care in Jamaica

Executive Summary

• AI/ML Innovations Inc. (AIML) announced the launch of a pilot program for its CardioYield™ AI‑powered Holter reporting platform at Heartdent Center in Kingston, Jamaica.
• The feasibility study will evaluate workflow integration and operational impact using a single‑lead ECG wearable chest strap combined with CardioYield™ software to deliver low‑cost, high‑accuracy cardiac diagnostics.
• Successful results are intended to create a foundation for broader deployment of the solution across Jamaica, expanding access to affordable cardiac care.

Key Details

• Partnership: AIML’s wholly owned subsidiary NeuralCloud Solutions Inc. is collaborating with Heartdent Center Ltd.; introduction facilitated by investor Wayne Isaacs.
• Pilot Scope: Evaluation of CardioYield™ workflow integration within a cardiology practice; utilizes a single‑lead ECG wearable chest strap linked to the AI platform.
• Objective: Demonstrate affordable, accurate, and scalable Holter diagnostics to address high cardiovascular mortality in Jamaica (≈ 33% of all deaths).
• Key Stakeholder Quotes:
• Dr. Geordan Goire Guevara (Founder & Medical Director, Heartdent Center) – emphasizes commitment to high‑level cardiac care and cost reduction.
• Esmat Naikyar (President, Neural Cloud & CPO, AIML) – highlights validation of real‑world workflow benefits.
• Paul Duffy (Executive Chairman & CEO, AIML) – notes urgent need for scalable diagnostics in Jamaica.
• Investor Comment: Wayne Isaacs stresses potential for improved patient outcomes through timely and accurate diagnosis.
• Future Plans: Pilot results will inform broader deployment strategy across the Jamaican market.

Notable Quotes

“Heartdent Center is committed to bringing the highest level of cardiac care to Jamaica… partnering with AIML enables us to pilot innovative technologies that reduce costs and improve access.” – Dr. Geordan Goire Guevara

“This pilot marks an important step in extending CardioYield's impact beyond North America…” – Esmat Naikyar

“Our goal is to demonstrate how CardioYield, combined with single lead ECG wearable devices, can provide a full solution that sets a new standard of care.” – Paul Duffy

Materiality Assessment: Non‑Material – Positive (the announcement provides a positive operational update but does not contain immediate financial impact or material earnings information).